[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NL279406A - - Google Patents

Info

Publication number
NL279406A
NL279406A NL279406DA NL279406A NL 279406 A NL279406 A NL 279406A NL 279406D A NL279406D A NL 279406DA NL 279406 A NL279406 A NL 279406A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL279406A publication Critical patent/NL279406A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NL279406D 1961-06-16 NL279406A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH707361A CH396008A (de) 1961-06-16 1961-06-16 Verfahren zur Herstellung von Sulfonamiden der Pyrimidinreihe

Publications (1)

Publication Number Publication Date
NL279406A true NL279406A (zh)

Family

ID=4319495

Family Applications (1)

Application Number Title Priority Date Filing Date
NL279406D NL279406A (zh) 1961-06-16

Country Status (8)

Country Link
US (1) US3132139A (zh)
BE (1) BE618639A (zh)
CH (1) CH396008A (zh)
DE (1) DE1218454B (zh)
DK (1) DK98960C (zh)
GB (1) GB951026A (zh)
NL (1) NL279406A (zh)
OA (1) OA00944A (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2319592A1 (en) 1998-02-03 1999-08-05 University Of Maryland Method for the stimulation of sperm production and gonadal development in animals
GB0217431D0 (en) * 2002-07-27 2002-09-04 Astrazeneca Ab Novel compounds
EP2311827A1 (en) * 2004-08-28 2011-04-20 AstraZeneca AB Thiopyrimidine derivative, useful as an intermediate for chemokine receptor modulators.
MX2011000402A (es) * 2008-07-16 2011-03-15 Astrazeneca Ab Derivado de pirimidil sulfonamida y su uso para el tratamiento de enfermedades mediadas por quimiocinas.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2410793A (en) * 1940-03-01 1946-11-05 American Cyanamid Co Sulfonamido pyrimidines
GB866843A (en) * 1958-12-08 1961-05-03 Ici Ltd Sulphonamidopyrimidines
BE588170A (fr) * 1959-03-04 1960-09-01 Ici Ltd Composés hétérocycliques.

Also Published As

Publication number Publication date
OA00944A (fr) 1968-03-22
GB951026A (en) 1964-03-04
US3132139A (en) 1964-05-05
DE1218454B (de) 1966-06-08
DK98960C (da) 1964-06-08
CH396008A (de) 1965-07-31
BE618639A (fr) 1962-12-14

Similar Documents

Publication Publication Date Title
BE621821A (zh)
BE601532A (zh)
BE599016A (zh)
BE598861A (zh)
BE599528A (zh)
NL279406A (zh)
BE587184A (zh)
BE583834A (zh)
BE568568A (zh)
BE567723A (zh)
BE493336A (zh)
BE482264A (zh)
BE692973A (zh)
BE626024A (zh)
BE624390A (zh)
BE624141A (zh)
BE622907A (zh)
BE622861A (zh)
BE622619A (zh)
BE622352A (zh)
BE621960A (zh)
BE478349A (zh)
BE621408A (zh)
BE617575A (zh)
BE596839A (zh)